Literature DB >> 32071054

Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo.

Jia Di1,2, Jun Zhang2, Lei Cao1, Ting-Ting Huang1, Jun-Xia Zhang1, Yan-Ni Mi1, Xue Xiao1, Ping-Ping Yan1, Man-Li Wu1, Tong Yao1, Dong-Zheng Liu1, Jing Liu1, Yong-Xiao Cao3.   

Abstract

Helicobacter pylori is an important risk factor for gastric ulcers. However, antibacterial therapies increase the resistance rate and decrease the eradication rate of H. pylori Inspired by the microaerophilic characteristics of H. pylori, we aimed at effectively establishing an oxygen-enriched environment to eradicate and prevent the recurrence of H. pylori The effect and the mechanism of an oxygen-enriched environment in eradicating H. pylori and preventing the recurrence were explored in vitro and in vivo During oral administration and after drug withdrawal, H. pylori counts were evaluated by Giemsa staining in animal cohorts. An oxygen-enriched environment in which H. pylori could not survive was successfully established by adding hydrogen peroxide into several solutions and rabbit gastric juice. Hydrogen peroxide effectively killed H. pylori in Columbia blood agar and special peptone broth. Minimum inhibition concentrations and minimum bactericidal concentrations of hydrogen peroxide were both relatively stable after promotion of resistance for 30 generations, indicating that hydrogen peroxide did not easily promote resistance in H. pylori In models of Mongolian gerbils and Kunming mice, hydrogen peroxide has been shown to significantly eradicate and effectively prevent the recurrence of H. pylori without toxicity and damage to the gastric mucosa. The mechanism of hydrogen peroxide causing H. pylori death was related to the disruption of bacterial cell membranes. The oxygen-enriched environment achieved by hydrogen peroxide eradicates and prevents the recurrence of H. pylori by damaging bacterial cell membranes. Hydrogen peroxide thus provides an attractive candidate for anti-H. pylori treatment.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Helicobacter pylorizzm321990; disruption; eradication; oxygen; resistance

Mesh:

Substances:

Year:  2020        PMID: 32071054      PMCID: PMC7179623          DOI: 10.1128/AAC.02192-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  Eradication rates in Italian subjects heterogeneously managed for Helicobacter pylori infection. Time to abandon empiric treatments in Southern Europe.

Authors:  Agostino Di Ciaula; Giuseppe Scaccianoce; Marino Venerito; Angelo Zullo; Leonilde Bonfrate; Theodore Rokkas; Piero Portincasa
Journal:  J Gastrointestin Liver Dis       Date:  2017-06       Impact factor: 2.008

2.  Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting?

Authors:  Pedro Boal Carvalho; Joana Magalhães; Francisca Dias de Castro; Bruno Rosa; José Cotter
Journal:  Acta Med Port       Date:  2017-03-31

Review 3.  The Impact of Oxygen on Bacterial Enteric Pathogens.

Authors:  N Wallace; A Zani; E Abrams; Y Sun
Journal:  Adv Appl Microbiol       Date:  2016-05-18       Impact factor: 5.086

4.  Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).

Authors:  Dafr Allah Benajah; Mounia Lahbabi; Samia Alaoui; Karima El Rhazi; Mohammed El Abkari; Chakib Nejjari; Afaf Amarti; Bahia Bennani; Mustapha Mahmoud; Sidi Adil Ibrahimi
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-04-06       Impact factor: 2.947

Review 5.  Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Muhan Lü; Shan Yu; Jiaqi Deng; Qiong Yan; Chun Yang; Guodong Xia; Xian Zhou
Journal:  PLoS One       Date:  2016-10-10       Impact factor: 3.240

6.  Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis.

Authors:  Christine S M Lau; Amanda Ward; Ronald S Chamberlain
Journal:  Infect Drug Resist       Date:  2016-12-07       Impact factor: 4.003

Review 7.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

8.  Rapid evolution of distinct Helicobacter pylori subpopulations in the Americas.

Authors:  Kaisa Thorell; Koji Yahara; Elvire Berthenet; Daniel J Lawson; Jane Mikhail; Ikuko Kato; Alfonso Mendez; Cosmeri Rizzato; María Mercedes Bravo; Rumiko Suzuki; Yoshio Yamaoka; Javier Torres; Samuel K Sheppard; Daniel Falush
Journal:  PLoS Genet       Date:  2017-02-23       Impact factor: 5.917

9.  A single nucleotide change affects fur-dependent regulation of sodB in H. pylori.

Authors:  Beth M Carpenter; Hanan Gancz; Reyda P Gonzalez-Nieves; Abby L West; Jeannette M Whitmire; Sarah L J Michel; D Scott Merrell
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  In vitro evaluation of the risk of inducing bacterial resistance to disinfection treatment with photolysis of hydrogen peroxide.

Authors:  Hiroyo Ikai; Yu Odashima; Taro Kanno; Keisuke Nakamura; Midori Shirato; Keiichi Sasaki; Yoshimi Niwano
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

View more
  1 in total

Review 1.  Animal Models and Helicobacter pylori Infection.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.